Frontiers in Cardiovascular Medicine

Original Research

Published on 09 Mar 2023

Differential expression of epigenetic modifiers in early and late cardiotoxic heart failure reveals DNA methylation as a key regulator of cardiotoxicity

in Cardio-Oncology

Emma L. Robinson
Pietro Ameri
Leen Delrue
Marc Vanderheyden
Jozef Bartunek
Paola Altieri
Stephane Heymans
Ward A. Heggermont

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.884174

3,099 views
7 citations

Review

Published on 07 Mar 2023

Emerging trends and hotspots evolution in cardiotoxicity: A bibliometric and knowledge-Map analysis From 2010 to 2022

in Cardio-Oncology

Di Xiao
Jingen Li
Yong Liu
Tangshun Wang
Chaofeng Niu
Rui Zhuang
Birong Liu
Liyong Ma
Meng Li
Lijing Zhang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1089916

3,688 views
4 citations

Original Research

Published on 03 Mar 2023

Association between thyroid cancer and cardiovascular disease: A meta-analysis

in Cardio-Oncology

Wen-Hsuan Tsai
Yi-Hong Zeng
Chun-Chuan Lee
Ming-Nan Chien
Sung-Chen Liu
Kuo-Liong Chien
Shih-Ping Cheng
Po-Jung Tseng
Ming-Chieh Tsai

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1075844

3,923 views
3 citations

Case Report

Published on 01 Mar 2023

Surgical resection of a giant cardiac angiosarcoma and reconstruction of involved right heart structures: A case report

in Cardio-Oncology

Andreea Blindaru
Alexandru Vasilescu
Andrei Danet
Oana Zimnicaru
Maximilian Cristu
Stefan Tudorica
Tudor Borjog
Oana Patrascu
Catalin Constantin Badiu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1115962

1,536 views
1 citation

General Commentary

Published on 27 Feb 2023

Commentary: “Multimodality advanced cardiovascular and molecular imaging for early detection and monitoring of cancer therapy-associated cardiotoxicity and the role of artificial intelligence and big data”

in Cardio-Oncology

Louise Y. Sun
Gift Echefu
Krishna Doshi
Michelle L. Roberts
Abdulaziz Hamid
Richard K. Cheng
Jessica Olson
Sherry-Ann Brown

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.982028

1,769 views
2 citations

Mini Review

Published on 21 Feb 2023

Chimeric antigen receptor-T cell therapy-related cardiotoxicity in adults and children cancer patients: A clinical appraisal

in Cardio-Oncology

Massimiliano Camilli
Luca Maggio
Lorenzo Tinti
Priscilla Lamendola
Gaetano Antonio Lanza
Filippo Crea
Antonella Lombardo

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1090103

3,909 views
12 citations

Review

Published on 17 Feb 2023

Galectin functions in cancer-associated inflammation and thrombosis

in Cardio-Oncology

Linus Kruk
Attila Braun
Erika Cosset
Thomas Gudermann
Elmina Mammadova-Bach

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1052959

6,739 views
12 citations

Case Report

Published on 15 Feb 2023

A case report of sudden cardiac arrest and torsade de pointes induced by the second-generation tyrosine kinase inhibitor dasatinib combined with fluconazole

in Cardio-Oncology

Yuting Yuan
Chunjian Wang
Hongying Yao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.984572

2,595 views
4 citations

Study Protocol

Published on 10 Feb 2023

Protocol for pyrotinib cardiac safety in patients with HER2-positive early or locally advanced breast cancer–The EARLY-MYO-BC study

in Cardio-Oncology

Yezi Chai
Meng Jiang
Yaohui Wang
Qiming Liu
Qifan Lu
Zhengyu Tao
Qizhen Wu
Wenjin Yin
Jinsong Lu
Jun Pu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1021937

2,951 views
2 citations

Case Report

Published on 09 Feb 2023

Case report: The diagnostic challenge of primary cardiac intimal sarcoma

in Cardio-Oncology

Naili Ye
Lan Lan
Huijuan Hu
Jinping Liu
Haibo Xu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1089636

2,756 views
5 citations

Original Research

Published on 08 Feb 2023

Artificial intelligence-augmented analysis of contemporary procedural, mortality, and cost trends in carcinoid heart disease in a large national cohort with a focus on the “forgotten pulmonic valve”

in Cardio-Oncology

Dominique J. Monlezun
Andrew Badalamenti
Awad Javaid
Kostas Marmagkiolis
Kevin Honan
Jin Wan Kim
Rishi Patel
Bindu Akhanti
Dan Halperin
Arvind Dasari

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1071138

4,849 views
4 citations

Case Report

Published on 08 Feb 2023

Case report: Persistent ST-segment elevation due to cardiac metastasis from lung cancer

in Cardio-Oncology

Jiawei Zhou
Chengchuang Zhan
Jing Zhou
Chao Wei
Cao Zou

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1001527

2,028 views
4 citations

Original Research

Published on 07 Feb 2023

In-hospital and one-year outcomes in cancer patients receiving percutaneous coronary intervention for acute myocardial infarction: A real-world study

in Cardio-Oncology

Manyun Tang
Yidan Wang
Xiangqi Cao
John D. Day
Hui Liu
Chaofeng Sun
Guoliang Li

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1005473

2,213 views

Original Research

Published on 07 Feb 2023

Five-year cardiovascular outcomes in patients with chronic myeloid leukemia treated with imatinib, dasatinib, or nilotinib: A cohort study using data from a large multinational collaborative network

in Cardio-Oncology

Rafael Amorim Belo Nunes
Precil Diego Miranda de Menezes Neves
Leandro Menezes Alves da Costa
Philip Bachour
Marcelo José de Carvalho Cantarelli
Gustavo Bernardes de Figueiredo Oliveira
Álvaro Avezum Jr.

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.888366

4,980 views
1 citation

Editorial

Published on 01 Feb 2023

Editorial: HF2Cancer: Exploring bidirectional interaction between cardiovascular diseases and cancer

in Cardio-Oncology

Canan G. Nebigil
Michael W. Y. Chan

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1145780

989 views

Original Research

Published on 25 Jan 2023

Higher risk of cardiovascular mortality than cancer mortality among long-term cancer survivors

in Cardio-Oncology

Zhipeng Wang
Zeyu Fan
Lei Yang
Lifang Liu
Chao Sheng
Fengju Song
Yubei Huang
Kexin Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1014400

4,557 views
23 citations

Navigation group

Articles

Differential expression of epigenetic modifiers in early and late cardiotoxic heart failure reveals DNA methylation as a key regulator of cardiotoxicity

Emerging trends and hotspots evolution in cardiotoxicity: A bibliometric and knowledge-Map analysis From 2010 to 2022

Association between thyroid cancer and cardiovascular disease: A meta-analysis

Surgical resection of a giant cardiac angiosarcoma and reconstruction of involved right heart structures: A case report

Commentary: “Multimodality advanced cardiovascular and molecular imaging for early detection and monitoring of cancer therapy-associated cardiotoxicity and the role of artificial intelligence and big data”

Chimeric antigen receptor-T cell therapy-related cardiotoxicity in adults and children cancer patients: A clinical appraisal

Galectin functions in cancer-associated inflammation and thrombosis

A case report of sudden cardiac arrest and torsade de pointes induced by the second-generation tyrosine kinase inhibitor dasatinib combined with fluconazole

Protocol for pyrotinib cardiac safety in patients with HER2-positive early or locally advanced breast cancer–The EARLY-MYO-BC study

Case report: The diagnostic challenge of primary cardiac intimal sarcoma

Artificial intelligence-augmented analysis of contemporary procedural, mortality, and cost trends in carcinoid heart disease in a large national cohort with a focus on the “forgotten pulmonic valve”

Case report: Persistent ST-segment elevation due to cardiac metastasis from lung cancer

In-hospital and one-year outcomes in cancer patients receiving percutaneous coronary intervention for acute myocardial infarction: A real-world study

Five-year cardiovascular outcomes in patients with chronic myeloid leukemia treated with imatinib, dasatinib, or nilotinib: A cohort study using data from a large multinational collaborative network

Editorial: HF2Cancer: Exploring bidirectional interaction between cardiovascular diseases and cancer

Higher risk of cardiovascular mortality than cancer mortality among long-term cancer survivors